Consistently, immunohistochemistry staining confirmed that mRIP3R479K overexpression increased tumor Gr1+ MDSC, while inhibited CD8+ T cells and Granzyme B+ cytotoxic cells (Figs. 4I and S4C–E). This evidence concerns the gene CD8A and neoplasm.